We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Endovascular Mesh Treats Cerebral Vasospasm

By HospiMedica International staff writers
Posted on 08 Dec 2020
An adjustable endovascular device facilitates mechanical dilation of intracranial vessels suffering from vasospasm. More...


The Rapid Medical (Yokneam, Israel) Comaneci adjustable remodeling mesh is a fully-visible wire stent, primarily intended for aneurysm, that is permanently affixed to the end of an internal core wire for delivery via an endovascular approach; once positioned, the wire is withdrawn distally, thus expanding the mesh, creating radial dilation of the contracted intracranial vessel. As the expansion is sequential, users can gradually increase the applied force while monitoring dilatation, thus lowering the risk of vessel injury.

Features include a non-occlusive design that maintains blood supply to the brain; stable positioning; high vessel compliance; microcatheter support; adjustable proprietary FlexiBraid technology to provide incremental shaping control; and 100% radiopaque wires that provide realtime feedback. Three sizes are available: Comaneci, with a length of 32 mm, for vessels with a diameter of 1.5-4.5 mm; Comaneci Petit, with a length of 24 mm, suitable for vessels with a diameter of 1.5-3.5 mm; and the Comaneci 17, with a length of 22 mm, suitable for vessels with a diameter of 0.5-3 mm.

“Data collected from our procedures in Europe suggest Comaneci's safe and successful performance in the mechanical dilation of intracranial vasospastic vessels,” said Walid Haddad, MD, chief clinical officer of Rapid Medical. “Mechanical dilation was successful in almost all cases, and was typically accompanied by significant neurological improvement. I believe that this procedure can meaningfully improve patient outcomes of this severe disease.”

Cerebral vasospasm is a devastating complication of subarachnoid hemorrhage, a type of hemorrhagic stroke. The spasms cause a narrowing of brain blood vessels, reducing blood flow. This occurs in 70% of patients and leads to neurological deterioration in up to 30%. Balloon angioplasty has so far been the main therapy for symptomatic patients, but such balloons block blood flow to the already ischemic brain tissue and also carry a risk of vessel perforation.

Related Links:
Rapid Medical


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Ureteral Dilatation Balloon
Dornier Equinox
Floor‑Mounted Digital X‑Ray System
MasteRad MX30+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The new 3D heart mapping system visualizes all four chambers in real time (Photo courtesy of UPV)

Whole-Heart Mapping Technology Provides Comprehensive Real-Time View of Arrhythmias

Cardiac arrhythmias can be difficult to diagnose and treat because current mapping systems analyze the heart one chamber at a time. This fragmented view forces clinicians to infer electrical activity they... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.